Chandramouli Nagarajan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Locally Advanced

Multiple Myeloma

Top Venues

PharmacoEconomics - open

JCO oncology practice

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open 8 (5) (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Diana Beatriz S Bayani, Yihao Clement Lin, Chandramouli Nagarajan, Melissa Gaik-Ming Ooi, Allison Ching Yee Tso, John Cairns, Hwee Lin Wee
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers. PharmacoEconomics - open (2024)
Chia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan, Wee-Joo Chng, Yen-Lin Chee, Melissa Gaik-Ming Ooi, Lawrence Cheng Kiat Ng, Yunxin Chen, Joanne Su Yin Yoong, Xin Yi Wong, Wei-Ying Jen
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent Lymphoma. JCO oncology practice (2023)
Michal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, Yanfen Peng, Shruti Sridhar, Phuong Mai Hoang, Clementine Xin Liu, Sanjay De Mel, Limei Michelle Poon, Esther Hian Li Chan, Joanne Lee, Choon-Kiat Ong, Tiffany Tang, Soon Thye Lim, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Soo Yong Tan, Susan Swee Shan Hue, Sheng-Tsung Chang, Shih-Sung Chuang, Shaoying Li, Joseph D Khoury, Hyung Won Choi, Carl Harris Iii, Alessia Bottos, Laura J Gay, Hendrik F P Runge, Ilias Moutsopoulos, Irina I Mohorianu, Daniel James Hodson, Pedro Farinha, Anja Mottok, David W Scott, Jason J Pitt, Jinmiao Chen, Gayatri Kumar, Kasthuri Kannan, Wee-Joo Chng, Yen-Lin Chee, Siok Bian Ng, Claudio Tripodo, Anand D Jeyasekharan
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer discovery (2023)
Tricia Hui Chyi Tay, Nagavalli Somasundaram, Cindy Lim, Lay Poh Khoo, Allan Zhi Kai Goh, Yuh Shan Lee, Xin Liu, Miriam Tao, Richard Quek, Mohamad Farid, Eileen Poon, Jason Y S Chan, Esther W Y Chang, Valerie S W Yang, Yeow Tee Goh, Daryl Tan, Colin Diong, Nicholas F Grigoropoulos, Chandramouli Nagarajan, Michelle Poon, Sanjay de Mel, Anand Jeyasekharan, Esther H L Chan, Joanne Lee, Yen Lin Chee, Soon Thye Lim, Tiffany Tang
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy. Cancer reports (Hoboken, N.J.) 5 (9) (2022)
Jasmine Goh, Sanjay De Mel, Michal Marek Hoppe, Masturah Bte Mohd Abdul Rashid, Xi Yun Zhang, Patrick Jaynes, Esther Ka Yan Ng, Nur'Atiqa Diana Binti Rahmat, null Jayalakshmi, Clementine Xin Liu, Limei Poon, Esther Chan, Joanne Lee, Yen Lin Chee, Liang Piu Koh, Lip Kun Tan, Teck Guan Soh, Yi Ching Yuen, Hoi-Yin Loi, Siok Bian Ng, Xueying Goh, Donovan Eu, Stanley Loh, Sheldon Ng, Daryl Tan, Daryl Ming Zhe Cheah, Wan Lu Pang, Dachuan Huang, Shin Yeu Ong, Chandramouli Nagarajan, Jason Yongsheng Chan, Jeslin Chian Hung Ha, Lay Poh Khoo, Nagavalli Somasundaram, Tiffany Tang, Choon-Kiat Ong, Wee-Joo Chng, Soon Thye Lim, Edward Kai-Hua Chow, Anand D Jeyasekharan
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma. Science translational medicine 14 (667) (2022)
Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Rehena Sultana, Li Hui Lim, Nicholas Francis Grigoropoulos, Shin Yeu Ong, Mingge Xu, null null, Wee-Joo Chng, Yeow Tee Goh, Chandramouli Nagarajan
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1). Blood cancer journal 11 (9) (2021)